Clora CEO Rahul Chaturvedi hosts an inspiring new episode of the Biotech2050 podcast featuring Robert Ang, CEO of Vor Bio. Dive into an engaging discussion on next-gen cancer therapies, including Vor’s shielded CD33-deleted stem cell transplants and CAR-T cell therapies for AML and MDS. Robert also shares his unique approach to building passionate and impactful teams. Listen using the link below. #Clora #biotech #podcast #cancer #stemcelltransplant
Excited to have Robert Ang, CEO of Vor Bio, join us on the latest episode! With a focus on developing next-gen cancer therapies, Vor Bio is making waves in the biotech industry. In this episode hosted by Rahul Chaturvedi, CEO of Clora, Robert shares insights into the current state of cancer therapies and Vor Bio's innovative approaches, including shielded stem cell transplants and CAR T-cell therapies targeting hematologic malignancies like AML and MDS. He also discusses his experience serving on boards and his unique approach to talent and building teams, prioritizing passion and impact over titles. Tune in for an insightful discussion on the future of cancer treatment and the role of VorBio in shaping it! #Biotech #CancerTherapies #Innovation #Leadership #Healthcare #Podcast #Biotech2050 Listen now: https://lnkd.in/dRhnCm5a